These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported Terminated 2006-001530-40 Vascular targeted photodynamic therapy using WST09 for patients with untreated localised prostate cancer - Repeat procedure – Phase IIa, Single centre, open-label study. 2008-10-17 due-trials
Listed as ongoing, but also has a completion date 2008-000876-26 "VASCULAR-TARGETED PHOTODYNAMIC THERAPY USING WST11 IN PATIENTS WITH LOCALISED PROSTATE CANCE" 2009-03-09 bad-data
Ongoing 2009-011895-31 EVALUATION OF THE SAFETY AND EFFICACY OF WST11 MEDIATED VASCULAR TARGETED PHOTODYNAMIC THERAPY ON OBSTRUCTING ENDOBRONCHIAL NON-SMALL CELL LUNG CANCER not-yet-due
Ongoing 2009-011897-14 EVALUATION OF THE SAFETY AND EFFICACY OF WST11-MEDIATED VASCULAR TARGETED PHOTODYNAMIC THERAPY ON NON-RESECTABLE OR INOPERABLE CHOLANGIOCARCINOMA not-yet-due
Listed as ongoing, but also has a completion date 2009-012809-19 VASCULAR-TARGETED PHOTODYNAMIC THERAPY USING WST11 IN PATIENTS WITH LOCALISED PROSTATE CANCER 2011-12-15 bad-data
Ongoing 2009-017435-18 A Phase IIa, Safety and Preliminary Effects Study of WST11 (Stakel®)-Mediated Vascular-Targeted Photodynamic (VTP) Therapy in Subjects with Choroidal Neovasularization (CNV) Associated with Age-Relate... not-yet-due
Not reported 2010-021900-93 A European Randomised Phase 3 Study to Assess the Efficacy and Safety of TOOKAD Soluble for Localised Prostate Cancer Compared to Active Surveillance Studio europeo randomizzato di Fase 3 eseguit... 2020-06-30 due-trials
Other 2020-004494-41 Multicenter Phase 3 Pivotal Study to Evaluate the Safety and Efficacy of TOOKAD (padeliporfin) Vascular Targeted Photodynamic Therapy in the Treatment of Low Grade Upper Tract Urothelial Cancer not-yet-due